Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 196 AL 210

[Tau-targeted drugs for dementia]

Furukawa K.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:93-7.

ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinic

Hopkins CR.

ACS Chem Neurosci. 2011 Jun 15;2(6):279-80. doi: 10.1021/cn2000469.

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease

Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Münch G.

Neurobiol Aging. 2011 May;32(5):763-77. doi: 10.1016/j.neurobiolaging.2009.04.016. Epub 2009 May 22.

Future targeted disease modifying drugs for Alzheimer's disease

Dash SK.

Recent Pat CNS Drug Discov. 2011 Jan;6(1):65-76. doi: 10.2174/157488911794079073.

Plasma concentration of donepezil to the therapeutic response of Alzheimer's disease in Taiwanese

Yang YH, Wu SL, Chou MC, Lai CL, Chen SH, Liu CK.

J Alzheimers Dis. 2011;23(3):391-7. doi: 10.3233/JAD-2010-100936.

The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study

De Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage CA, Pasquier F.

Eur J Neurol. 2011 Jun;18(6):913-8. doi: 10.1111/j.1468-1331.2010.03329.x. Epub 2011 Jan 18.

Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease

Ballard C, Corbett A, Sharp S.

Expert Rev Neurother. 2011 Mar;11(3):327-9. doi: 10.1586/ern.11.13.

[Prescription differences of dementia drugs in urban and rural areas in Germany]

Bohlken J, Selke GW, van den Bussche H.

Psychiatr Prax. 2011 Jul;38(5):232-6. doi: 10.1055/s-0030-1266020. Epub 2011 Mar 21.

Ginseng

Barton D.

Oncology (Williston Park). 2011 Apr;25(4 Suppl Nurse Ed):42-5.

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

Bak AM, Egefjord L, Gejl M, Steffensen C, Stecher CW, Smidt K, Brock B, Rungby J.

Expert Opin Ther Targets. 2011 Oct;15(10):1153-62. doi: 10.1517/14728222.2011.600691. Epub 2011 Jul 12.

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab

Carlson C, Estergard W, Oh J, Suhy J, Jack CR Jr, Siemers E, Barakos J.

Alzheimers Dement. 2011 Jul;7(4):396-401. doi: 10.1016/j.jalz.2011.05.2353.

Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway

Andersen F, Viitanen M, Halvorsen DS, Straume B, Engstad TA.

BMC Geriatr. 2011 Oct 4;11:58. doi: 10.1186/1471-2318-11-58.

Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment

Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.

Neurobiol Aging. 2011 Jan;32(1):15-23. doi: 10.1016/j.neurobiolaging.2009.01.013. Epub 2009 Feb 27.

Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment

Molinuevo JL, Berthier ML, Rami L.

Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):18-22. doi: 10.1016/j.archger.2009.11.004. Epub 2009 Nov 30.

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease

Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.

Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias